Humana members receive free drug co-pay

Why Digital Innovation Will Transform the Future of Smart Pharmacy | NCPDP 2025

The announcement comes shortly after the company announced it had filed its second chapter 11 bankruptcy in under 2 years.

Brian Nowosielski;Vin Gupta, MD

FDA Approves Dihydroergotamine as Auto Injectable for Migraine Treatment

NBC News Medical Analyst Vin Gupta, MD, joins Drug Topics at NCPDP 2025 to discuss the technological evolution of the pharmacy profession.

Pharmacy Law Lowdown: PBM Audit Trends, Enforcement Actions

Dihydroergotamine (Brekiya) is an acute treatment to help relieve migraine attacks, and it can come in nasal sprays, injections, and intravenous infusions.

Killian Meara;Dae Lee, PharmD, Esq, CPBS ;Lucas Morgan, Esq

May 14th 2025

Q&A: What the Most-Favored-Nation Drug Pricing Executive Order Means for Community Pharmacy

Dae Lee, PharmD, Esq, CPBS and Lucas Morgan, Esq, discuss PBM and board of pharmacy enforcement actions, trends in PBM audits, and more.

Brian Nowosielski;Ronna Hauser, PharmD

Online Obesity Clinics Report Consistent Weight Loss With Lower Doses of Semaglutide

Ronna Hauser, PharmD, Senior Vice President of Policy & Pharmacy Affairs at NCPA, provides insights into President Trump’s most recent executive order regarding manufacturer drug prices.

Rite Aid to Sell Pharmacy Assets From Over 1,000 Stores to CVS, Walgreens

Investigators report that patients experience weight loss with a reduced weekly dosage of the glucagon-like peptide-1 (GLP-1).

Related Content

Killian Meara

Why Digital Innovation Will Transform the Future of Smart Pharmacy | NCPDP 2025

The announcement comes shortly after the company announced it had filed its second chapter 11 bankruptcy in under 2 years.

Brian Nowosielski;Vin Gupta, MD

FDA Approves Dihydroergotamine as Auto Injectable for Migraine Treatment

NBC News Medical Analyst Vin Gupta, MD, joins Drug Topics at NCPDP 2025 to discuss the technological evolution of the pharmacy profession.

Pharmacy Law Lowdown: PBM Audit Trends, Enforcement Actions

Dihydroergotamine (Brekiya) is an acute treatment to help relieve migraine attacks, and it can come in nasal sprays, injections, and intravenous infusions.

Killian Meara;Dae Lee, PharmD, Esq, CPBS ;Lucas Morgan, Esq

May 14th 2025

Q&A: What the Most-Favored-Nation Drug Pricing Executive Order Means for Community Pharmacy

Dae Lee, PharmD, Esq, CPBS and Lucas Morgan, Esq, discuss PBM and board of pharmacy enforcement actions, trends in PBM audits, and more.

Brian Nowosielski;Ronna Hauser, PharmD

Online Obesity Clinics Report Consistent Weight Loss With Lower Doses of Semaglutide

Ronna Hauser, PharmD, Senior Vice President of Policy & Pharmacy Affairs at NCPA, provides insights into President Trump’s most recent executive order regarding manufacturer drug prices.